Friday, March 29, 2024
Home Tags NYSE: XXII

Tag: NYSE: XXII

22nd Century to Participate in May and June 2021 Investor Conferences

0
BUFFALO, N.Y., May 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused...

22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN®...

0
BUFFALO, N.Y., May 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused...

22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further...

0
Applauds Decisive Move and Commitment by FDA to Advance Rule Banning Menthol As First Step to Reduce Addiction, Improve Quitting, Reduce Youth Initiation...

22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for...

0
To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine Content Research Cigarettes for Numerous Independent Scientific Studies Research on Nicotine...

22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine...

0
BUFFALO, N.Y., April 08, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News